Merck KGaA vs Arthur J. Gallagher & Co.
Comparaison de la capitalisation boursière au fil du temps
Merck KGaA
$63.3B
Rang #248
Arthur J. Gallagher & Co.
$64.9B
Rang #246
Capitalisation boursière au fil du temps
Moments clés
- Arthur J. Gallagher & Co. a dépassé Merck KGaA avant 1999
- Merck KGaA a dépassé Arthur J. Gallagher & Co. avant 2007
- Arthur J. Gallagher & Co. a dépassé Merck KGaA avant 2008
- Merck KGaA a dépassé Arthur J. Gallagher & Co. avant 2015
- Arthur J. Gallagher & Co. a dépassé Merck KGaA avant 2017
Comparaison année par année
| Année | Merck KGaA | Arthur J. Gallagher & Co. | Leader |
|---|---|---|---|
| 2026 | $63.3B | $64.9B | Arthur J. Gallagher & Co. |
| 2025 | $16.8B | $65.9B | Arthur J. Gallagher & Co. |
| 2024 | $18.8B | $71.7B | Arthur J. Gallagher & Co. |
| 2023 | $19.1B | $56.4B | Arthur J. Gallagher & Co. |
| 2022 | $23.6B | $46.7B | Arthur J. Gallagher & Co. |
| 2021 | $29.3B | $41.5B | Arthur J. Gallagher & Co. |
| 2020 | $18.0B | $29.8B | Arthur J. Gallagher & Co. |
| 2019 | $13.3B | $22.6B | Arthur J. Gallagher & Co. |
| 2018 | $11.2B | $17.1B | Arthur J. Gallagher & Co. |
| 2017 | $11.0B | $14.4B | Arthur J. Gallagher & Co. |
| 2016 | $12.0B | $11.5B | Merck KGaA |
| 2015 | $10.7B | $8.7B | Merck KGaA |
| 2014 | $9.3B | $9.7B | Arthur J. Gallagher & Co. |
| 2013 | $7.6B | $9.4B | Arthur J. Gallagher & Co. |
| 2012 | $5.8B | $6.8B | Arthur J. Gallagher & Co. |
| 2011 | $4.4B | $6.2B | Arthur J. Gallagher & Co. |
| 2010 | $3.3B | $5.2B | Arthur J. Gallagher & Co. |
| 2009 | $3.6B | $3.8B | Arthur J. Gallagher & Co. |
| 2008 | $3.4B | $4.1B | Arthur J. Gallagher & Co. |
| 2007 | $4.7B | $3.7B | Merck KGaA |
| 2006 | $4.1B | $4.3B | Arthur J. Gallagher & Co. |
| 2005 | $3.6B | $4.3B | Arthur J. Gallagher & Co. |
| 2004 | $2.6B | $4.4B | Arthur J. Gallagher & Co. |
| 2003 | $1.6B | $4.2B | Arthur J. Gallagher & Co. |
| 2002 | $1.2B | $3.7B | Arthur J. Gallagher & Co. |
| 2001 | $1.9B | $4.3B | Arthur J. Gallagher & Co. |
| 2000 | $2.1B | $3.9B | Arthur J. Gallagher & Co. |
| 1999 | $1.3B | $1.9B | Arthur J. Gallagher & Co. |
| 1998 | $1.7B | $1.3B | Merck KGaA |